Quick Read

Jonathan Cohn details how the Trump administration's policies are systematically undermining federal medical research funding and Medicaid, threatening future scientific breakthroughs and access to healthcare.
A recent pancreatic cancer breakthrough, like many others, was built on decades of federal research funding.
The Trump administration is attacking medical research through bureaucratic freezes, political vetting of grants, and targeting universities.
New Medicaid work requirements are designed to kick eligible people off coverage via complex paperwork, not to promote work.

Summary

Jonathan Cohn, author and Bulwark newsletter writer, discusses the Trump administration's multi-pronged attack on medical research and Medicaid. He highlights a recent pancreatic cancer drug breakthrough, emphasizing its reliance on decades of federal funding, which is now at risk. Cohn explains how bureaucratic interference, politically motivated grant approvals, and attacks on universities are starving the research ecosystem. Concurrently, new Medicaid work requirements, exemplified by experiments in Arkansas and Georgia, are designed to reduce enrollment through complex bureaucracy, disproportionately affecting vulnerable populations and externalizing healthcare costs. The long-term consequences include a potential 'brain drain' and a loss of the next generation of scientists, with the American public unlikely to connect future medical stagnation to current policy decisions.
The systematic dismantling of federal medical research funding and critical healthcare programs like Medicaid poses a severe, long-term threat to public health and scientific innovation in the United States. These policies risk stifling future medical breakthroughs, exacerbating health disparities, and shifting healthcare costs to other sectors, ultimately undermining the nation's capacity to address critical health challenges and remain a global leader in science.

Takeaways

  • Federal funding is the bedrock of major medical breakthroughs, including a recent pancreatic cancer drug.
  • The Trump administration employs a 'three-pronged attack' on medical research: bureaucratic interference, political alignment requirements for grants, and targeting universities.
  • Grants are being frozen, delayed, or canceled, starving research labs of essential funds.
  • A proposed rule mandates that all medical research grants align with the administration's political priorities, including views on gender and sexual orientation.
  • Universities, key engines of medical innovation, are being 'stiffed' on funding, with institutions like Harvard disproportionately affected.
  • Medicaid work requirements, as seen in Arkansas and Georgia, increase bureaucracy and cost, leading to eligible individuals losing coverage.
  • The definition of 'medically frail' for Medicaid exemptions has been narrowed, requiring proof that conditions prevent work, creating confusion and barriers.
  • The long-term impact includes a 'brain drain' of scientists to other countries and a significant reduction in funding for early-career researchers, jeopardizing future innovation.

Insights

1Federal Funding Underpins Major Medical Breakthroughs

A recent, highly celebrated breakthrough in pancreatic cancer treatment, involving a new drug targeting the KRAS gene, directly resulted from decades of foundational federal research funding. Institutions like Dana-Farber, Sloan Kettering, and UCLA, along with the National Cancer Institute, were instrumental, tracing their work back to basic biological understandings and projects like the Human Genome Project, all supported by public investment.

The guest details the development of a pancreatic cancer drug, explaining how researchers identified a small pocket on the KRAS gene over 15 years ago, leading to NCI investigation and subsequent discoveries at leading US research institutions. He states, 'Federal research funding undergirds all of that. It is decades of work. It's this foundation of scientific knowledge we have built.'

2Three-Pronged Attack on Medical Research Infrastructure

The Trump administration is undermining medical research through a systematic approach: bureaucratic interference (freezing grants, complicating applications, firing advisory boards), imposing political tests on grant funding (requiring alignment with administration priorities on issues like gender), and directly attacking universities (stiffing institutions perceived as 'woke'). This creates an environment where scientific merit is secondary to political alignment.

Cohn describes 'a sort of three-pronged attack' involving 'general bureaucratic interference' (), a 'systematic effort to just change the way grants are given out' by aligning with 'priorities of the administration' (), and an 'attack on universities' (). He cites examples like grants being suspended for containing the word 'diversity' ().

3Medicaid Cuts Through Bureaucratic Work Requirements

The administration is implementing new Medicaid work requirements designed to reduce enrollment by creating overly complex paperwork and administrative hurdles. This leads to eligible individuals, particularly those with chronic health conditions, mental illness, or limited access to technology, losing their insurance, as demonstrated by previous experiments in Arkansas and Georgia.

Cohn explains that work requirements 'make the paperwork and the bureaucracy so complex, that people can't get through it.' He notes that in Arkansas and Georgia, 'lots of people lost their insurance, even though they were satisfying the work requirements.' He also highlights the stricter interpretation of 'medically frail' exemptions, requiring proof of inability to work, not just a condition.

4Long-Term Brain Drain and Loss of Future Scientists

The cuts and political interference in research funding are causing a 'brain drain,' with scientists considering moving to other countries. More critically, the reduction in 'early career awards' and other foundational grants for PhD students means the next generation of groundbreaking researchers will not be cultivated, leading to a significant loss of future innovation and leadership in science.

Cohn mentions 'stories, people going to Canada' and China attracting 'prominent mathematicians, computer scientists' (). He emphasizes the impact on 'young scientists who are not going to be coming in' due to cuts to 'early career awards' from the National Science Foundation, which historically produced 'Nobel Prize winners, founders of industry.'

Lessons

  • Educate yourself on how federal funding underpins medical research and healthcare programs to understand the long-term implications of policy changes.
  • Engage with political processes, such as voting or contacting elected officials, to advocate for sustained and depoliticized funding for scientific research and robust social safety nets like Medicaid.
  • Support organizations that champion scientific integrity and universal healthcare access, as these are critical to counteracting policies that undermine public health and innovation.

Quotes

"

"Federal research funding undergirds all of that. It is decades of work. It's this foundation of scientific knowledge we have built. We have the United States have long had we are distinguished for having the biggest public investment in medical research. It's why we are world leader in this kind of innovation, and that's how we got here, and that is, you know, unfortunately, what's now at risk."

Jonathan Cohn
"

"You're sort of subjecting science to a political test it's never been uh subjected to before."

Jonathan Cohn
"

"The mentality of the bill, the mentality of the Trump administration is that too many people are on Medicaid, it should be a last resort. I think they feel like if we're going to have to err on one side or the other, we'd rather too few people have this than too many."

Jonathan Cohn

Q&A

Recent Questions

Related Episodes